Image

The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The study aims to evaluate the effect of home-based walking program on peripheral neuropathy, fatigue and quality of life in patients receiving taxane and platinum-based chemotherapy.

Description

The study was designed as a randomized controlled trial. This study will be carried out with a total of 86 cancer patients receiving taxane and platinum-based chemotherapy, 43 of whom were in the intervention group and 43 in the control group, whose treatment was started in Akdeniz University Hospital."Home Based Walking Program" will be applied to the patients in the intervention group for 8 weeks.Within the scope of the Home-Based Walking Program, face-to-face patient education, patient education booklet, sending text messages, face-to-face and telephone counseling were planned.

Patient Identification Form, International Physical Activity Questionnaire (IPAQ- Short Form), National Cancer Institute (NCI) -CTCAE v5.0 Toxicity Criteria, Cancer Fatigue Scale, EORTC QLQ-CIPN20 (Quality of Life Chemotherapy-Induced Peripheral Neuropathy) and EORTC QLQ-C30 (Quality of Life Scale), Interview Form will be used to collect data.

Eligibility

İnclusion Criteria

  • 18 Years and older (Adult, Older Adult )
  • Turkish speaking-understanding ability and literate.
  • Orientation (person, place, time)
  • Receiving taxane and platinum-based chemotherapy treatment (monotherapy or combined).
  • Receiving chemotherapy treatment for the first time.
  • The primary medical diagnosis is cancer (breast cancer, colorectal cancers and other cancers).
  • Not having health problems that prevent walking.
  • Agreeing to participate in the research.

Exclusion Criteria

  • Being bone and brain metastases
  • Being peripheral neuropathy due to reasons other than chemotherapy (such as chronic disease, diabetes mellitus, nutritional disorders)
  • Skin sensitivity on the hands and feet
  • Having cardiovascular, pulmonary, musculoskeletal, or psychological disorders that limit exercise or mobility
  • Being in another supportive program
  • Being in the very active category according to the "International Physical Activity Scale (IPAQ- Short Form)"
  • Being a severity of more than 4 points according to the "Modified Borg Scale (MBS)"
  • Being a score of 2 and above according to the "ECOG Performance Scale"

Study details

Chemotherapeutic Toxicity

NCT06012253

Akdeniz University Hospital

15 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.